Tandem Diabetes Care Inc
TNDMNasdaqCIK 1438133HealthcareFiscal year ends Dec 31
Reports and events: 246 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0616:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001438133-26-000125 |
| 2026-08-0616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-26-000124 |
| 2026-05-2116:10 ET | 8-K | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001438133-26-000070 |
| 2026-05-1507:59 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001438133-26-000052 |
| 2026-05-0716:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001438133-26-000049 |
| 2026-05-0716:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-26-000048 |
| 2026-04-0716:23 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001438133-26-000034 |
| 2026-02-2716:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-007142 |
| 2026-02-1916:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001438133-26-000010 |
| 2026-02-1916:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-26-000009 |
| 2025-12-3016:29 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001438133-25-000237 |
| 2025-11-1209:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001438133-25-000190 |
| 2025-11-0616:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001438133-25-000187 |
| 2025-11-0616:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-25-000186 |
| 2025-08-0716:09 ET | 8-K | 8.01 Other events | 0001438133-25-000160 |
| 2025-08-0616:23 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001438133-25-000157 |
| 2025-08-0616:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-25-000155 |
| 2025-05-2316:21 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results | 0001438133-25-000112 |
| 2025-05-2018:28 ET | 8-K | 8.01 Other events | 0001438133-25-000091 |
| 2025-05-1217:16 ET | 8-K | 8.01 Other events | 0001438133-25-000072 |
| 2025-04-3016:11 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001438133-25-000069 |
| 2025-04-3016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-25-000068 |
| 2025-04-0817:10 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001438133-25-000058 |
| 2025-02-2616:09 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001438133-25-000036 |
| 2025-02-2616:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-25-000035 |
| 2024-11-0616:11 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001438133-24-000201 |
| 2024-11-0616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-24-000200 |
| 2024-08-0116:11 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001438133-24-000177 |
| 2024-08-0116:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-24-000176 |
| 2024-06-2116:19 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001438133-24-000166 |
| 2024-06-1816:31 ET | 8-K | 1.01 Entry into a material agreement | 0001438133-24-000158 |
| 2024-05-2316:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001438133-24-000118 |
| 2024-05-1616:35 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001438133-24-000088 |
| 2024-05-0216:12 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001438133-24-000086 |
| 2024-05-0216:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-24-000085 |
| 2024-04-0916:54 ET | DEF 14A | Proxy statementPeriod 2024-04-09 | 0001438133-24-000076 |
| 2024-04-0116:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001438133-24-000047 |
| 2024-03-1118:19 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001438133-24-000042 |
| 2024-02-2116:33 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001438133-24-000028 |
| 2024-02-2116:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-24-000026 |
| 2023-12-1118:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001438133-23-000253 |
| 2023-11-1318:44 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001438133-23-000210 |
| 2023-11-0619:42 ET | 8-K | 8.01 Other events | 0001628280-23-036843 |
| 2023-11-0116:08 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001438133-23-000207 |
| 2023-11-0116:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-23-000206 |
| 2023-08-1816:53 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001438133-23-000179 |
| 2023-08-0316:08 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001438133-23-000153 |
| 2023-08-0316:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438133-23-000152 |
| 2023-05-2619:39 ET | 8-K | 5.07 Shareholder vote results | 0001438133-23-000094 |
| 2023-05-0316:12 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001438133-23-000067 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:09 ET. Listed shows no prices and gives no investment advice.